C9 and amyotrophic lateral sclerosis: DNA bisulfite sequencing and methylation sensitivity assays performed on ALS patients carrying the C9-NRE mutation have shown that the C9orf72 promoter and NRE region itself can have 5mC hypermethylation at CpG sites32–34.